loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for Tertomotide Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Tertomotide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 PolyPeptide Group
    Switzerland
    		 Samsung Pharmaceutical Co., Ltd. No. 2617-1-ND(1)-A Tertomotide hydrochloride 2015-02-26 PolyPeptide SA Belgium Chaussee de Tubize 297, Braine-l'Alleud, 1420 Belgium